Grifols SA (GRFS)
8.19
+0.35
(+4.46%)
USD |
NASDAQ |
May 20, 16:00
8.19
0.00 (0.00%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly) : 0.1255 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cellectis SA | -0.1774 |
| Biodexa Pharmaceuticals Plc | -- |
| Amarin Corp. Plc | -0.501 |
| Akari Therapeutics Plc | 0.00 |
| NuCana Plc | -1.28 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 102.95M |
| Revenue (Quarterly) | 1.989B |
| Total Expenses (Quarterly) | 1.903B |
| Enterprise Value | 18.42B |
| Gross Profit Margin (Quarterly) | 36.47% |
| Profit Margin (Quarterly) | 5.18% |
| Earnings Yield | 8.63% |
| Operating Earnings Yield | 25.46% |
| Normalized Earnings Yield | 8.264 |